Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors
- 1 February 2021
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 32, 116000
- https://doi.org/10.1016/j.bmc.2021.116000
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
This publication has 64 references indexed in Scilit:
- Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1Antimicrobial Agents and Chemotherapy, 2013
- Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 PocketViruses, 2013
- Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and RilpivirineAntimicrobial Agents and Chemotherapy, 2012
- Design, Synthesis, and Antiviral Activity of Entry Inhibitors That Target the CD4-Binding Site of HIV-1Journal of Medicinal Chemistry, 2012
- Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loopsProceedings of the National Academy of Sciences of the United States of America, 2012
- HIV envelope: challenges and opportunities for development of entry inhibitorsTrends in Microbiology, 2011
- Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screeningBioorganic & Medicinal Chemistry, 2011
- Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from IndiaVirology, 2009
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionProceedings of the National Academy of Sciences of the United States of America, 2008
- Thermodynamics of Binding of a Low-Molecular-Weight CD4 Mimetic to HIV-1 gp120Biochemistry, 2006